Company intelligence

NUWE

Nuwellis, Inc. · NASDAQ · Healthcare

Price$1.05+9.45% · +$0.09

Market cap96.79KEquity value

P / E-0.5Trailing ratio

Volume22.41MLatest session

Market data

NUWE price chart

TradingView

Related signals

1 min delayed

Browse public NUWE signals with their source context and measured market impact. Open any signal for its permanent analysis page.

NUWEJul 30, 2026-60.90% since signal

NUWE rises on pediatric study; Aquadex momentum ahead of results

NUWE rose after Frontiers in Pediatrics accepted a retrospective study on epoprostenol for Aquadex, signaling a potential bleeding-risk reduction. The momentum aligns with its pediatric push, highlighted by a Wisconsin hospital installation and 14% Q2 revenue growth, keeping the August 13 results date in focus as a near-term catalyst.

View signal analysis

NUWEJan 27, 2026+0.26% since signal

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Nuwellis Inc experienced a dramatic stock surge driven by a board overhaul and patent news. The new directors may indicate a strategic shift, while the pediatric patent strengthens their niche market position, attracting retail investors and potentially larger strategic interests in the company.

View signal analysis

Research